PARK AVENUE SECURITIES LLC

Broker-Dealer

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1071640 NEW YORK, NY

Position in HALO

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$789,666

+$119,389 QoQ

Shares Held

10,089

-2.7% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#334

of 664 holders

Holding Since

Sep 2022

13 quarters on record

Healthcare · as of Jun 30, 2026

PARK AVENUE SECURITIES LLC holds $18,019,918 across 22 Biotechnology names. HALO ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	10,198	$5,065,652
2	RPRX	Royalty Pharma plc	46,965	$2,633,327
3	INSM	INSMED Inc	9,927	$1,058,416
4	REGN	Regeneron Pharmaceuticals, Inc.	1,563	$974,593
5	EXEL	Exelixis, Inc.	16,542	$900,050
6	ARGX	Argenx SE	956	$886,948
7	JAZZ	Jazz Pharmaceuticals plc	3,608	$869,419
8	HALO	Halozyme Therapeutics, Inc. This page	10,089	$789,666

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$789,666	10,089	-2.7%	Shares	Sole	2026-07-20
2026-03-31	$670,277	10,371	-4.4%	Shares	Sole	2026-04-07
2025-09-30	$795,298	10,844	-9.3%	Shares	Sole	2025-10-23
2025-06-30	$622,107	11,959	-13.3%	Shares	Sole	2025-07-14
2025-03-31	$880,322	13,796	+10.9%	Shares	Sole	2025-04-14
2024-12-31	$594,708	12,439	+6.9%	Shares	Sole	2025-01-14
2024-09-30	$666,159	11,638	+25.2%	Shares	Sole	2024-10-03
2024-06-30	$486,686	9,295	+12.1%	Shares	Sole	2024-07-09
2024-03-31	$337,399	8,294	+17.3%	Shares	Sole	2024-04-10
2023-12-31	$261,270	7,069	-7.8%	Shares	Sole	2024-01-10
2023-09-30	$292,726	7,663	-0.1%	Shares	Sole	2023-10-26
2022-12-31	$436,309	7,668	+16.3%	Shares	Sole	2023-01-24
2022-09-30	$260,608	6,591	—	Shares	Sole	2022-11-01
No filing history on record for this holder in this stock.